Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kraml

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Organic Letters|April 25, 2013
A congested in,in-diphosphineJie Zong, Joel T Mague, Christina M Kraml, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Etodolac kinetics in the elderlyJ Scatina, D Hicks, M Kraml, et al.
Drug Metabolism Reviews|January 1, 1981
The metabolic disposition of etodolac in rats, dogs, and manM N Cayen, M Kraml, E S Ferdinandi, et al.
Pharmaceutical Research|September 1, 1993
The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperaturesM Dey, R Enever, M Kraml, et al.
Journal of the American Chemical Society|September 19, 2008
Thermal C1-C5 diradical cyclization of enediynesChandrasekhar Vavilala, Neal Byrne, Christina M Kraml, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritisM Kraml, D R Hicks, M McKean, et al.
Clinical Pharmacology and Therapeutics|March 1, 1992
The effect of renal disease on tolrestat pharmacokineticsS M Troy, D R Hicks, M Kraml, et al.
Plant Physiology|May 1, 1994
Isolation of a full-length cDNA encoding cytosolic enolase from Ricinus communisS D Blakeley, C Dekroon, K P Cole, et al.
Mbio|March 10, 2021
Saccharomyces cerevisiae Requires <i>CFF1</i> To Produce 4-Hydroxy-5-Methylfuran-3(2H)-One, a Mimic of the Bacterial Quorum-Sensing Autoinducer AI-2Julie S Valastyan, Christina M Kraml, Istvan Pelczer, et al.
Biopharmaceutics & Drug Disposition|April 1, 1981
Butriptyline: human pharmacokinetics and comparative bioavailability of conventional and sustained release formulationsJ Bourgouin, M A Gagnon, R Elie, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Organic Letters|April 25, 2013
A congested in,in-diphosphineJie Zong, Joel T Mague, Christina M Kraml, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Etodolac kinetics in the elderlyJ Scatina, D Hicks, M Kraml, et al.
Drug Metabolism Reviews|January 1, 1981
The metabolic disposition of etodolac in rats, dogs, and manM N Cayen, M Kraml, E S Ferdinandi, et al.
Pharmaceutical Research|September 1, 1993
The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperaturesM Dey, R Enever, M Kraml, et al.
Journal of the American Chemical Society|September 19, 2008
Thermal C1-C5 diradical cyclization of enediynesChandrasekhar Vavilala, Neal Byrne, Christina M Kraml, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritisM Kraml, D R Hicks, M McKean, et al.
Clinical Pharmacology and Therapeutics|March 1, 1992
The effect of renal disease on tolrestat pharmacokineticsS M Troy, D R Hicks, M Kraml, et al.
Plant Physiology|May 1, 1994
Isolation of a full-length cDNA encoding cytosolic enolase from Ricinus communisS D Blakeley, C Dekroon, K P Cole, et al.
Mbio|March 10, 2021
Saccharomyces cerevisiae Requires <i>CFF1</i> To Produce 4-Hydroxy-5-Methylfuran-3(2H)-One, a Mimic of the Bacterial Quorum-Sensing Autoinducer AI-2Julie S Valastyan, Christina M Kraml, Istvan Pelczer, et al.
Biopharmaceutics & Drug Disposition|April 1, 1981
Butriptyline: human pharmacokinetics and comparative bioavailability of conventional and sustained release formulationsJ Bourgouin, M A Gagnon, R Elie, et al.
Pageof 7